Cervical cancer is caused by the human papillomavirus (HPV). The virus can be acquired through not only penile-vaginal sexual intercourse but also sexual behavior, such as skin-to-skin and digital-genital contact with a sexual partner of any sex. There is now a vaccine that can prevent young women and girls from becoming infected with HPV and developing cervical cancer.
Why did the researchers do this particular study?
The authors wanted to know whether lesbian and bisexual women and girls were receiving the HPV vaccine as often as heterosexual women and girls.
Who was studied? 3253 women and girls aged 15 to 25 years.
How was the study done?
The study used data from a national survey in which participants were asked about their sociodemographic characteristics and health care.
What did the researchers find?
The authors found that young women and girls who had heard of the HPV vaccine and identified as lesbian in the survey were less likely to initiate HPV vaccination than heterosexual women and girls of the same age.
What were the limitations of the study?
There were not many women and girls in the survey group who identified as lesbians, and this made it more difficult to accurately compare their results with those of heterosexual women and girls.
What are the implications of the study?
The authors believe that more studies should be conducted with larger samples of lesbian women and girls to better understand why this population is not receiving the HPV vaccine. Do lesbians believe that they are not at risk for HPV and cervical cancer? Do their health care providers believe that they are not at risk and thus do not recommend the vaccine? Based on their findings, the authors recommend the development of targeted programs that promote access to opt-out services for HPV vaccination among adolescent and young adult lesbians. 
